Cargando…

COVID-19: from hospitals to courts – Author's reply

Detalles Bibliográficos
Autor principal:	Usuelli, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062087/ https://www.ncbi.nlm.nih.gov/pubmed/33894828 http://dx.doi.org/10.1016/S0140-6736(21)00463-3

Ejemplares similares

COVID-19: from hospitals to courts
por: Magnavita, Nicola, et al.
Publicado: (2021)

Cancer and COVID-19 – Authors' reply
por: Kuderer, Nicole M, et al.
Publicado: (2020)

Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020)

COVID-19 and preterm birth – Authors' reply
por: Choudhary, Rahul, et al.
Publicado: (2021)

Neuropsychiatric disorders and COVID-19 – Authors' reply
por: Taquet, Maxime, et al.
Publicado: (2021)

COVID-19 and myocardial infarction – Authors' reply
por: Katsoularis, Ioannis, et al.
Publicado: (2021)

COVID-19 research in LMICs – Authors' reply
por: Torres, Irene, et al.
Publicado: (2021)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

COVID-19 in patients with HIV – Authors' reply
por: Miró, José M, et al.
Publicado: (2020)

Fluvoxamine for the treatment of COVID-19 – Author's reply
por: Reis, Gilmar, et al.
Publicado: (2022)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

Risk factors for in-hospital mortality in patients with cancer and COVID-19 – Authors' reply
por: Yang, Kunyu, et al.
Publicado: (2020)

Cortisol concentrations and mortality from COVID-19 – Authors' reply
por: Tan, Tricia, et al.
Publicado: (2020)

The Lombardy region of Italy launches the first investigative COVID-19 commission
por: Usuelli, Michele
Publicado: (2020)

Reply from the authors
por: Solomon, C., et al.
Publicado: (2014)

Azithromycin for mild-to-moderate COVID-19 – Authors' reply
por: Hinks, Timothy S C
Publicado: (2021)

Antipsychotics and COVID-19: the debate goes on – Authors' reply
por: De Picker, Livia, et al.
Publicado: (2021)

WHO COVID-19 therapeutic guidelines – Authors' reply
por: White, Nicholas J, et al.
Publicado: (2021)

COVID-19 and global mental health – Authors' reply
por: Kola, Lola, et al.
Publicado: (2021)

COVID-19 and maternal and perinatal outcomes – Authors' reply
por: Chmielewska, Barbara, et al.
Publicado: (2021)

Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021)

Frailty and mortality in patients with COVID-19 – Authors' reply
por: McCarthy, Kathryn, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19 – Authors' reply
por: Hayem, Gilles, et al.
Publicado: (2020)

Psychiatric and neuropsychiatric syndromes and COVID-19 – Authors' reply
por: Rogers, Jonathan P, et al.
Publicado: (2020)

Management of diabetes in patients with COVID-19 – Authors' reply
por: Bornstein, Stefan R, et al.
Publicado: (2020)

Surgery during the COVID-19 pandemic – Authors' reply
por: COVIDSurg Collaborative
Publicado: (2020)

Depression and anxiety during COVID-19 – Authors' reply
por: Santomauro, Damian F, et al.
Publicado: (2022)

Authors' Reply
por: Zhen, Wei, et al.
Publicado: (2021)

Authors’ Reply
por: Pramanik, Raja, et al.
Publicado: (2021)

Authors' reply
por: Griffin, Lucy, et al.
Publicado: (2021)

Authors' reply
por: Griffin, Lucy, et al.
Publicado: (2021)

Author's reply:
por: Morgan, Gethin
Publicado: (2021)

Authors' Reply
por: Bush, Eliot C, et al.
Publicado: (2006)

Author's Reply
por: Kaeberlein, Matt, et al.
Publicado: (2006)

Authors' Reply
por: van Nimwegen, Erik, et al.
Publicado: (2006)

Authors' Reply
por: Nguyen, Hung D, et al.
Publicado: (2006)

Author’s reply
por: Manikandan, S
Publicado: (2011)

Author's Reply
por: Sharma, Sushil
Publicado: (2011)

Authors' reply
por: Khilnani, Gurudas
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_9s9aov4ud1552c311dhe5hf6dq